Baijin Life Science Holdings Limited (1466.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Baijin Life Science Holdings Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
84
First IPO Date
October 17, 2014
Key Executives
| Name | Title | Pay | Year Born |
| Yaoyao Su | Executive Director | 506,000 | 1983 |
| Peng Dong | Executive Director | 506,000 | 1989 |
| Sze Ming Cheung | Chief Financial Officer, Company Secretary & Executive Director | 902,000 | 1969 |
Description
Affluent Partners Holdings Limited, an investment holding entity founded in 2014 and situated in Central, Hong Kong, conducts various operations. Its core business involves the full lifecycle of pearls and jewelry products, including their acquisition, processing, design, manufacturing, assembly, trading, and wholesale distribution. The company's activities are structured into two distinct divisions: the sale of pearl and jewelry items, and strategic investment alongside financial services. Additionally, it allocates capital to financial assets within the real estate sector. Affluent Partners operates internationally, with a footprint in Hong Kong, the United Kingdom, the United States, Japan, Europe, and mainland China. This enterprise was previously known as Man Sang Jewellery Holdings Limited, undergoing a name change to Affluent Partners Holdings Limited in February 2017.